These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33068303)

  • 41. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
    Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
    Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Precision Pharmacotherapy Enables Precision Medicine.
    Bishop JR; Ellingrod VL
    Pharmacotherapy; 2017 Sep; 37(9):985-987. PubMed ID: 28836287
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of drug transporter characterization to precision medicine.
    Fisel P; Nies AT; Schaeffeler E; Schwab M
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):361-365. PubMed ID: 28140687
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy.
    Mueller BA; Smoyer WE
    Clin Pharmacol Ther; 2009 Nov; 86(5):479-82. PubMed ID: 19844225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 48. Precision versus approximation: the trade off in assessing kidney function and drug dosing.
    Richardson MM
    Pharmacotherapy; 2010 Aug; 30(8):758-61. PubMed ID: 20653350
    [No Abstract]   [Full Text] [Related]  

  • 49. Personalized Drug Dosage - Closing the Loop.
    Tucker GT
    Pharm Res; 2017 Aug; 34(8):1539-1543. PubMed ID: 27943015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenoconversion and therapeutic drug monitoring.
    de Leon J
    Br J Clin Pharmacol; 2015 Oct; 80(4):777-8. PubMed ID: 25881716
    [No Abstract]   [Full Text] [Related]  

  • 51. Deep Digital Phenotyping and Digital Twins for Precision Health: Time to Dig Deeper.
    Fagherazzi G
    J Med Internet Res; 2020 Mar; 22(3):e16770. PubMed ID: 32130138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives in Primary Care: Knowing the Patient as a Person in the Precision Medicine Era.
    Ziegelstein RC
    Ann Fam Med; 2018 Jan; 16(1):4-5. PubMed ID: 29311168
    [No Abstract]   [Full Text] [Related]  

  • 53. Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS Workshop.
    Younis IR; Robert Powell J; Rostami-Hodjegan A; Corrigan B; Stockbridge N; Sinha V; Zhao P; Jadhav P; Flamion B; Cook J
    J Clin Pharmacol; 2017 Jan; 57(1):105-109. PubMed ID: 27365151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Personalised antimicrobial dosing: standing on the shoulders of giants.
    Wallenburg E; Ter Heine R; Schouten JA; Brüggemann RJM
    Int J Antimicrob Agents; 2020 Sep; 56(3):106062. PubMed ID: 32574792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Precise hepatectomy in the intelligent digital era.
    Chen H; He Y; Jia W
    Int J Biol Sci; 2020; 16(3):365-373. PubMed ID: 32015674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Imaging in the Era of Precision Medicine.
    Giardino A; Gupta S; Olson E; Sepulveda K; Lenchik L; Ivanidze J; Rakow-Penner R; Patel MJ; Subramaniam RM; Ganeshan D
    Acad Radiol; 2017 May; 24(5):639-649. PubMed ID: 28131497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.
    Euteneuer JC; Kamatkar S; Fukuda T; Vinks AA; Akinbi HT
    J Clin Pharmacol; 2019 Feb; 59(2):168-176. PubMed ID: 30204236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Promises of Quantitative Proteomics in Precision Medicine.
    Prasad B; Vrana M; Mehrotra A; Johnson K; Bhatt DK
    J Pharm Sci; 2017 Mar; 106(3):738-744. PubMed ID: 27939376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Overview of Drug Delivery Systems.
    Jain KK
    Methods Mol Biol; 2020; 2059():1-54. PubMed ID: 31435914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.
    Wei DQ; Chen Q
    Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.